Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06168604 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of the Pain Identification and Communication Toolkit
A NA study of Alzheimer Disease and Dementia, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 440
- Enrollment target
- 1
- Study location
NCT06168604: Recruiting NA study of Alzheimer Disease and Dementia, sponsored by Weill Medical College of Cornell University.
NCT06168604 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 440 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06168604, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 440 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techniques. It will recruit participants from programs of all-inclusive care for the elderly (PACE) and partnering health care clinics. The investigators hypothesize that PICT will help caregivers to recognize and communicate about pain in their care recipients.
Primary Outcome
Change in caregiver-reported pain-related communication as measured by ten questions from the Perceived Involvement in Care Scale (PICS). The range of possible scores is 10-50, where higher scores indicate greater caregiver involvement in patient consultation.
Conditions Studied
Interventions
- BEHAVIORAL Pain Identification and Communication Toolkit
- BEHAVIORAL Health Promotion Program
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2023-12-14 |
| Est. Completion | 2027-10-30 |
| Phase | NA |
What NCT06168604 shows while recruiting
NCT06168604 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% lower).
The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Pain Identification and Communication Toolkit is the first listed.
NCT06168604 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06168604 about?
NCT06168604 is a clinical study titled "Evaluating the Efficacy of the Pain Identification and Communication Toolkit". This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techni...
What is the current status of trial NCT06168604?
This trial is currently recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2023-12-14. Estimated completion is 2027-10-30.
What conditions does trial NCT06168604 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Cognitive Impairment, Pain, Chronic, Caregiver Burden.
What interventions are being tested in trial NCT06168604?
The interventions under investigation include: Pain Identification and Communication Toolkit (BEHAVIORAL), Health Promotion Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06168604?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06168604 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06168604's enrollment target sits among peer trials
440 61st of 306 higher than 246 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI